20 Stocks Insiders Bought in April After Trump’s Tariff Rollout

7. Owens & Minor, Inc. (NYSE:OMI)

Owens & Minor is a healthcare solutions company that provides medical products and services to healthcare providers worldwide. It operates in two segments: Products & Healthcare Services, offering medical supplies and services, and Patient Direct, delivering in-home care products for conditions like diabetes and sleep apnea.

In April, one insider acquired approximately $4.29 million worth of Owens & Minor shares at an average price of $8.17 per share. The stock now trades at $8.13 having lost 37.80% year-to-date, and 70.13% over the past 12 months.

For the full year 2024, Owens & Minor reported revenue of $10.70 billion, compared to revenue of $10.33 billion in 2023. Net loss was $363 million, compared to net loss of $41 million in the prior year. Adjusted EBITDA was a gain of $523 million, compared to adjusted EBITDA of $526 million in 2023.

According to TipRanks, five Wall Street analysts rate Owens & Minor stock as a “Hold” with a price target of $10.72 per share. The average price target suggests a 31.86% upside from the latest price.